425 related articles for article (PubMed ID: 11714827)
1. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
Soejima K; Rollins BJ
J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
[TBL] [Abstract][Full Text] [Related]
2. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
[TBL] [Abstract][Full Text] [Related]
3. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.
Jinquan T; Jing C; Jacobi HH; Reimert CM; Millner A; Quan S; Hansen JB; Dissing S; Malling HJ; Skov PS; Poulsen LK
J Immunol; 2000 Aug; 165(3):1548-56. PubMed ID: 10903763
[TBL] [Abstract][Full Text] [Related]
4. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
[TBL] [Abstract][Full Text] [Related]
5. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD
J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530
[TBL] [Abstract][Full Text] [Related]
6. The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan.
Yang J; Richmond A
Mol Ther; 2004 Jun; 9(6):846-55. PubMed ID: 15194051
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.
Romagnani P; Annunziato F; Lasagni L; Lazzeri E; Beltrame C; Francalanci M; Uguccioni M; Galli G; Cosmi L; Maurenzig L; Baggiolini M; Maggi E; Romagnani S; Serio M
J Clin Invest; 2001 Jan; 107(1):53-63. PubMed ID: 11134180
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.
Marx N; Mach F; Sauty A; Leung JH; Sarafi MN; Ransohoff RM; Libby P; Plutzky J; Luster AD
J Immunol; 2000 Jun; 164(12):6503-8. PubMed ID: 10843708
[TBL] [Abstract][Full Text] [Related]
9. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.
Cox MA; Jenh CH; Gonsiorek W; Fine J; Narula SK; Zavodny PJ; Hipkin RW
Mol Pharmacol; 2001 Apr; 59(4):707-15. PubMed ID: 11259614
[TBL] [Abstract][Full Text] [Related]
10. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
[TBL] [Abstract][Full Text] [Related]
12. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
Tensen CP; Flier J; Van Der Raaij-Helmer EM; Sampat-Sardjoepersad S; Van Der Schors RC; Leurs R; Scheper RJ; Boorsma DM; Willemze R
J Invest Dermatol; 1999 May; 112(5):716-22. PubMed ID: 10233762
[TBL] [Abstract][Full Text] [Related]
13. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
15. CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma.
Jinquan T; Quan S; Jacobi HH; Jing C; Millner A; Jensen B; Madsen HO; Ryder LP; Svejgaard A; Malling HJ; Skov PS; Poulsen LK
Blood; 2000 Aug; 96(4):1230-8. PubMed ID: 10942362
[TBL] [Abstract][Full Text] [Related]
16. Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat.
Poggi A; Carosio R; Fenoglio D; Brenci S; Murdaca G; Setti M; Indiveri F; Scabini S; Ferrero E; Zocchi MR
Blood; 2004 Mar; 103(6):2205-13. PubMed ID: 14630801
[TBL] [Abstract][Full Text] [Related]
17. Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke.
Wang X; Li X; Schmidt DB; Foley JJ; Barone FC; Ames RS; Sarau HM
Mol Pharmacol; 2000 Jun; 57(6):1190-8. PubMed ID: 10825390
[TBL] [Abstract][Full Text] [Related]
18. Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.
Hsieh MF; Lai SL; Chen JP; Sung JM; Lin YL; Wu-Hsieh BA; Gerard C; Luster A; Liao F
J Immunol; 2006 Aug; 177(3):1855-63. PubMed ID: 16849497
[TBL] [Abstract][Full Text] [Related]
19. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
[TBL] [Abstract][Full Text] [Related]
20. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]